10-K · February 26, 2026
Viatris reported 2025 total revenues of $14.30 billion and highlights execution on its strategy to reshape the business: pipeline progress (five positive Phase 3 readouts), targeted M&A (Aculys acquisition) and…
Earnings analysis · 10-Q
Filed May 7, 2026 · Our reading of the company's report
The latest report
Viatris reported a strong Q1 2026 performance with revenues of $3.51 billion, an 8% increase from the previous year, and EPS of $0.59, surpassing estimates by 16%. Key growth was driven by a significant 22% rise in the…
Viatris reported a strong Q1 2026 performance with revenues of $3.51 billion, an 8% increase from the previous year, and EPS of $0.59, surpassing estimates by 16%. Key growth was driven by a significant 22% rise in the Greater China segment, although gross margin decreased to 33% due to higher costs. Management reaffirmed fiscal 2026 guidance amid ongoing restructuring efforts and cost challenges.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Total revenues reached $3.51 billion in Q1 2026, up from $3.25 billion in Q1 2025, an increase of $262.7 million.
Reported EPS of $0.59 exceeded consensus estimates of $0.51, resulting in a 15.69% surprise.
Sales in the Greater China region grew by 22% to $680.1 million, significantly contributing to overall revenue growth.
Operating cash flow was $388.3 million, although down from $535.5 million the previous year.
Management confirmed revenue guidance of $14.45 billion to $14.95 billion for fiscal 2026.
Adjusted gross margin remained stable at 56% for both Q1 2026 and Q1 2025.
Cost of sales rose to $2.36 billion in Q1 2026, impacting gross margin which fell to 33%.
Viatris accrued $450.8 million for legal contingencies, which could impact financial performance.
Continued restructuring efforts have led to significant operational costs, which were about $92.5 million in Q1 2026.
Management reaffirmed their full-year guidance for revenue and adjusted EBITDA.
Viatris reported 2025 total revenues of $14.30 billion and highlights execution on its strategy to reshape the business: pipeline progress (five positive Phase 3 readouts), targeted M&A (Aculys acquisition) and…
Viatris reported Q1 total revenues of $3,254.3 million, down from $3,663.4 million a year ago, with gross margin of 35.7% and a GAAP diluted loss per share of $(2.55). Results were driven by a $2,936.8 million…
Viatris reported Q3 (three months ended September 30, 2024) total revenues of $3,751.2 million and diluted EPS of $0.08. Revenue, gross profit and operating income all declined versus the prior-year quarter while the…
Viatris reported Q2 total revenues of $3,796.6 million (down from $3,918.6 million in Q2 2023) and swung to a net loss of $326.4 million (vs. net income $264.0 million in Q2 2023), producing diluted EPS of $(0.27) (vs.…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.